Concord Biotech Ltd Quarterly Results

Gross Sales

247.06

203.99

429.88

244.22

310.18

Excise Duty

0

0

0

0

0

Net Sales

247.06

203.99

429.88

244.22

310.18

Other Operating Income

0

0

0

0

0

Other Income

15.64

15.17

9.38

16.56

10.03

Total Income

262.7

219.16

439.27

260.78

320.21

Total Expenditure

158.57

142.59

241.01

146.27

176.46

PBIDT

104.13

76.57

198.26

114.51

143.75

Interest

0.06

0.06

0.1

0.1

0.1

PBDT

104.08

76.51

198.16

114.42

143.65

Depreciation

18.39

17.78

14.62

13.26

13.31

Minority Interest Before NP

0

0

0

0

0

Tax

22

14.08

41.82

23.69

34.06

Deferred Tax

0.63

0.6

1.34

1.54

0.53

Reported Profit After Tax

63.06

44.06

140.39

75.92

95.74

Minority Interest After NP

-0.52

0

0

0

0

Net Profit after Minority Interest

63.58

44.06

140.39

75.92

95.74

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

63.58

44.06

140.39

75.92

95.74

EPS (Unit Curr.)

6.03

4.21

13.42

7.26

9.15

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.46

10.46

10.46

10.46

10.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

42.14

37.53

46.11

46.88

46.34

PBDTM(%)

42.12

37.5

46.09

46.85

46.31

PATM(%)

25.52

21.59

32.65

31.08

30.86